β2 adrenergic receptor-mediated signaling regulates the immunosuppressive potential of myeloid-derived suppressor

Hemn Mohammadpour1, Cameron R MacDonald1, Guanxi Qiao1

  • 1Department of Immunology, and.

Insights

Sympathetic nerve signaling via beta-2 adrenergic receptors (β2-AR) regulates myeloid-derived suppressor cells (MDSCs). Targeting β2-AR signaling may enhance cancer immunotherapy by modulating MDSC function and survival.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cancer Research

Background:

  • Catecholamines activate adrenergic receptors on various cells, including myeloid-derived suppressor cells (MDSCs).
  • β2-adrenergic receptors (β2-AR) play a role in immune cell function and tumor microenvironments.

Purpose of the Study:

  • To investigate the influence of β2-AR signaling on MDSC frequency, survival, and immunosuppressive functions.
  • To determine the mechanisms by which β2-AR signaling regulates MDSCs, including STAT3 phosphorylation and Fas-FasL interactions.
  • To explore the therapeutic potential of targeting β2-AR signaling in cancer immunotherapy.

Main Methods:

  • In vitro cell culture systems.
  • Murine tumor models (wild-type and β2-AR-/- mice).
  • Adoptive transfer of MDSCs.
  • Gene expression analysis.
  • Analysis of STAT3 phosphorylation and Fas-FasL interactions.

Main Results:

  • β2-AR signaling significantly impacts MDSC frequency and survival in tumors and other tissues.
  • β2-AR signaling modulates MDSC expression of immunosuppressive molecules (e.g., arginase-I, PD-L1) and their ability to suppress T cell proliferation.
  • β2-AR signaling in MDSCs is dependent on STAT3 phosphorylation and Fas-FasL interactions.
  • β2-AR signaling promotes MDSC generation from murine and human peripheral blood cells.
  • β-AR antagonists mitigate MDSC immunosuppressive function, while agonists enhance it.

Conclusions:

  • β2-AR signaling is a critical regulator of MDSC biology.
  • Targeting β2-AR signaling offers a potential strategy to overcome immune suppression in cancer.
  • Modulating β2-AR activity could enhance the efficacy of immunotherapy and other cancer treatments.

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.8K
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
16.1K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.2K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.5K
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
3.6K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.0K